Fatigue is a complex phenomenon and an important health concern for many people with
chronic inflammatory rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis …

Fatigue in rheumatoid arthritis is highly prevalent. It is correlated only weakly with disease
activity but more so with pain, mood, personality features, poor sleep, obesity and …

Objectives Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal
diseases (I-RMDs) and recognised as one of the most challenging symptoms to manage …

There is a lack of validated tools to measure fatigue in patients with inflammatory skin,
neuropsychiatric, and medical disorders. The use of nonvalidated tools may compromise the …

Abstract Interleukin (IL)-6 is produced locally in response to an inflammatory stimulus, and is
able to induce systemic manifestations at distance from the site of inflammation. Its unique …

Objective To identify the best evidence on the efficacy of non-pharmacological interventions
in reducing fatigue in people with inflammatory rheumatic and musculoskeletal diseases (I …

Objective To determine the effect of a multidisciplinary lifestyle program in patients with RA
with low–moderate disease activity. Methods In the 'Plants for Joints'(PFJ) parallel-arm …

Abstract Background The relationship between Mg (magnesium), Cu (copper), and K
(potassium) intakes and the risk of rheumatoid arthritis (RA) remains limited. The aim of …

Background Fatigue is a common and distressing symptom of heart failure (HF) and has
important implications for patient-reported and clinical outcomes. Despite being a common …

Objective Fatigue is common in rheumatoid arthritis (RA). We aimed to explore its
longitudinal course, predictors and association with disease activity in early RA. Methods …